Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Men and women, ages ≥ 18
Participants who are considered methotrexate inadequate responders (MTX-IR)
10 or more swollen joints (66 joint count) and 12 or more tender joints (68 joint count)
Participants were to have been enrolled in the main MTX-IR study and been treated with open label abatacept for at least 3 months in the long term period
You may not be if
Participants who failed one or multiple anti-tumor necrosis factor (TNF) therapies
Participants who meet diagnostic criteria for any other rheumatic disease (e.g., lupus erythematosus)
Participants with active vasculitis of a major organ system (except for subcutaneous rheumatoid nodules)
Participants with severe chronic or recurrent bacterial infections
Participants who have received treatment with rituximab
